G3BP/Rin-Binding Motifs Inserted into Flexible Regions of nsP2 Support RNA Replication of Chikungunya Virus.
G3BP
RNA replication
Rin
alphavirus
chikungunya virus
nsP2
nsP3
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
09 11 2022
09 11 2022
Historique:
pubmed:
14
10
2022
medline:
15
11
2022
entrez:
13
10
2022
Statut:
ppublish
Résumé
Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus. In infected cells, its positive-sense RNA genome is translated into polyproteins that are subsequently processed into four nonstructural proteins (nsP1 to 4), the virus-encoded subunits of the RNA replicase. However, for RNA replication, interactions between nsPs and host proteins are also needed. These interactions are mostly mediated through the intrinsically disordered C-terminal hypervariable domain (HVD) in nsP3. Duplicate FGDF motifs in the HVD are required for interaction with mammalian RasGAP SH3-binding proteins (G3BPs) and their mosquito homolog Rin; these interactions are crucial for CHIKV RNA replication. In this study, we inactivated G3BP/Rin-binding motifs in the HVD and inserted peptides containing either native or inactivated G3BP/Rin-binding motifs into flexible regions of nsP1, nsP2, or nsP4. Insertion of native motifs into nsP1 or nsP2 but not into the C terminus of nsP4 activated CHIKV RNA replication in human cells in a G3BP-dependent manner. In mosquito cells, activation also resulted from the insertion of inactive motifs after residue 8 or 466 in nsP2; however, the effect was significantly larger when the inserted sequence contained native motifs. Nonetheless, CHIKV mutants harboring mutations in the HVD and containing insertions of native motifs in nsP2 were not viable in mosquito cells. In contrast, mutant genomes containing native motifs after residue 466 or 618 in nsP2 replicated in BHK-21 cells, with the latter mutant forming infectious progeny. Thus, the binding of G3BPs to nsP2 can support CHIKV RNA replication and restore the infectivity of viruses lacking G3BP-binding motifs in the HVD of nsP3.
Identifiants
pubmed: 36226983
doi: 10.1128/jvi.01278-22
pmc: PMC9645214
doi:
Substances chimiques
RNA
63231-63-0
Viral Nonstructural Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0127822Références
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1666-1671
pubmed: 28143925
J Virol. 2015 Apr;89(8):4457-69
pubmed: 25653451
Proc Natl Acad Sci U S A. 2021 Feb 9;118(6):
pubmed: 33547245
mBio. 2020 Feb 11;11(1):
pubmed: 32047134
Adv Virus Res. 2021;111:111-156
pubmed: 34663497
J Virol. 2021 Feb 24;95(6):
pubmed: 33328310
EMBO J. 1994 Jun 15;13(12):2925-34
pubmed: 7517863
Microbiol Rev. 1994 Sep;58(3):491-562
pubmed: 7968923
J Virol. 2018 Jun 29;92(14):
pubmed: 29695431
PLoS Negl Trop Dis. 2018 Nov 9;12(11):e0006958
pubmed: 30412583
Parasit Vectors. 2015 Sep 17;8:464
pubmed: 26384002
Open Biol. 2016 Jul;6(7):
pubmed: 27383630
PLoS Pathog. 2019 Jan 22;15(1):e1007239
pubmed: 30668592
Nucleic Acids Res. 2022 Jan 25;50(2):1000-1016
pubmed: 35037043
PLoS One. 2011;6(12):e28923
pubmed: 22205980
J Biol Chem. 2014 Feb 28;289(9):5635-53
pubmed: 24407286
J Virol. 1980 Apr;34(1):108-18
pubmed: 6768898
FEBS Lett. 1999 Apr 1;448(1):19-22
pubmed: 10217401
PLoS Pathog. 2019 Jun 14;15(6):e1007842
pubmed: 31199850
Proc Natl Acad Sci U S A. 2019 May 7;116(19):9558-9567
pubmed: 31000599
Structure. 2006 Sep;14(9):1449-58
pubmed: 16962975
Biochem Biophys Res Commun. 2015 Nov 6;467(1):53-7
pubmed: 26410532
Mol Biol Cell. 2012 Dec;23(24):4701-12
pubmed: 23087212
PLoS Pathog. 2016 Aug 10;12(8):e1005810
pubmed: 27509095
PLoS One. 2016 Mar 10;11(3):e0151616
pubmed: 26963103
J Virol. 2012 Oct;86(19):10873-9
pubmed: 22837213
Biochem Soc Trans. 2002 Nov;30(Pt 6):963-9
pubmed: 12440955
J Virol. 2020 Dec 9;95(1):
pubmed: 33055253
Proc Natl Acad Sci U S A. 2018 Oct 30;115(44):E10457-E10466
pubmed: 30322911
Cell Host Microbe. 2021 May 12;29(5):757-764.e3
pubmed: 33730549
J Biol Chem. 2000 Sep 8;275(36):27775-83
pubmed: 10851234
J Virol. 2009 Jul;83(13):6534-45
pubmed: 19386706
Nature. 2021 Jan;589(7843):615-619
pubmed: 33328629
J Virol. 2021 Apr 12;95(9):
pubmed: 33568506
J Virol. 2013 Sep;87(18):10295-312
pubmed: 23864636
Nucleic Acids Res. 2019 Sep 26;47(17):9296-9312
pubmed: 31350895
J Virol. 2021 Jul 26;95(16):e0083621
pubmed: 34076483
Biophys J. 2015 Oct 6;109(7):1483-96
pubmed: 26445449
J Virol. 1997 Jan;71(1):392-7
pubmed: 8985362
Viruses. 2018 Apr 27;10(5):
pubmed: 29702546
J Biol Chem. 2001 Aug 17;276(33):30786-93
pubmed: 11410598
Genes Cells. 2013 Feb;18(2):135-46
pubmed: 23279204
J Virol. 2007 May;81(10):5046-57
pubmed: 17329335
J Virol. 2019 Aug 28;93(18):
pubmed: 31217251
Virology. 2009 Feb 5;384(1):201-8
pubmed: 19036396
PLoS Pathog. 2020 Sep 4;16(9):e1008825
pubmed: 32886709
J Cell Biol. 2016 Mar 28;212(7):845-60
pubmed: 27022092
J Virol. 2018 Jul 31;92(16):
pubmed: 29899097
J Clin Invest. 2017 Mar 1;127(3):737-749
pubmed: 28248203
Antiviral Res. 2017 Jul;143:38-47
pubmed: 28390873
Virology. 2019 Nov;537:130-142
pubmed: 31493651
Virol J. 2008 Sep 26;5:108
pubmed: 18822126
J Virol. 2021 Sep 27;95(20):e0035521
pubmed: 34319783
J Virol. 2018 Jun 29;92(14):
pubmed: 29695432
Virology. 1990 Nov;179(1):416-27
pubmed: 2145690
J Virol. 2020 Mar 17;94(7):
pubmed: 31941782
J Biol Chem. 2000 Jun 9;275(23):17281-7
pubmed: 10748213
Cell Rep. 2017 Jul 25;20(4):935-948
pubmed: 28746877
J Virol. 2010 Jul;84(13):6720-32
pubmed: 20392851
Sci Rep. 2016 Nov 15;6:37124
pubmed: 27845418
Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16534-9
pubmed: 23010928
J Virol. 1994 Sep;68(9):5804-10
pubmed: 8057461